Knickerbocker Aron Marc 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Jun 26, 2019
Insider Transaction Report
Form 4
Knickerbocker Aron Marc
SVP & Chief Business Officer
Transactions
- Award
Performance-Based Restricted Common Stock
2019-06-24+124,420→ 124,420 total→ Common Stock (124,420 underlying)
Footnotes (2)
- [F1]These shares will vest upon achievement of certain performance conditions, as further described in Footnote 2.
- [F2](i) 50% of the shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the "Company") is greater than or equal to $12.95, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2020; and (ii) 50% of the shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company is greater than or equal to $19.43, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2021; in each case, subject to the reporting person's continued service to the Company through each such date.